Aprepitant is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Sandoz Inc. The primary component is Aprepitant.
| Product ID | 0781-2323_6355a06a-3314-4666-adcb-ee10e732c3bc |
| NDC | 0781-2323 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Aprepitant |
| Generic Name | Aprepitant |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-12-27 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA090999 |
| Labeler Name | Sandoz Inc |
| Substance Name | APREPITANT |
| Active Ingredient Strength | 125 mg/1 |
| Pharm Classes | Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2016-12-27 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA090999 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-12-27 |
| Ingredient | Strength |
|---|---|
| APREPITANT | 125 mg/1 |
| SPL SET ID: | f58b8944-93ee-4be1-a238-cc0061ddd93a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0781-2321 | Aprepitant | aprepitant |
| 0781-2322 | Aprepitant | aprepitant |
| 68462-112 | Aprepitant | Aprepitant |
| 68462-583 | Aprepitant | Aprepitant |
| 68462-584 | Aprepitant | Aprepitant |
| 68462-585 | Aprepitant | Aprepitant |
| 0781-2323 | Aprepitant | Aprepitant |
| 0781-4063 | Aprepitant | Aprepitant |
| 13668-594 | APREPITANT | APREPITANT |
| 13668-591 | APREPITANT | APREPITANT |
| 13668-592 | APREPITANT | APREPITANT |
| 13668-593 | APREPITANT | APREPITANT |
| 0006-0461 | EMEND | aprepitant |
| 0006-0462 | EMEND | aprepitant |
| 0006-0464 | EMEND | aprepitant |
| 0006-3066 | EMEND | aprepitant |
| 0006-3862 | EMEND | aprepitant |